AARTI PHARMALABS
Back to Income Statement
|
AARTI PHARMALABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹217 Cr | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
What is the latest Consolidated Net Profit of AARTI PHARMALABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹217 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹122 Cr |
| Mar2022 | ₹-0.01 Cr |
| Mar2021 | ₹-0.01 Cr |
How is Consolidated Net Profit of AARTI PHARMALABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹217 Cr | 12.10 | |
| Mar2024 | ₹193 Cr | 58.28 | |
| Mar2023 | ₹122 Cr | Positive | |
| Mar2022 | ₹-0.01 Cr | Negative | |
| Mar2021 | ₹-0.01 Cr | - | |
Compare Consolidated Net Profit of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,282.9 Cr | 5.6% | 6.5% | 20.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 5.6% |
6.5% |
20.2% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses